{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:34:46Z","timestamp":1793378086519,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109066","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:42:27Z","timestamp":1785253347000},"page":"109066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management"],"prefix":"10.1016","volume":"261","author":[{"given":"Rong","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2026.109066_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/1744666X.2021.1905524","article-title":"Rheumatoid arthritis related interstitial lung disease","volume":"17","author":"Manfredi","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109066_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/BOR.0000000000000787","article-title":"Interstitial lung disease throughout the rheumatoid arthritis disease course","volume":"33","author":"McDermott","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"issue":"12","key":"10.1016\/j.rmed.2026.109066_bib3","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/acr.24856","article-title":"Incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis-associated interstitial lung disease: a population-based cohort","volume":"74","author":"Samhouri","year":"2022","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13075-024-03362-1","article-title":"Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study","volume":"26","author":"Song","year":"2024","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.rmed.2026.109066_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126460","article-title":"The lung in rheumatoid arthritis-friend or enemy?","volume":"25","author":"Anton","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.rmed.2026.109066_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MCP.0000000000000710","article-title":"Recent advances in rheumatoid arthritis-associated interstitial lung disease","volume":"26","author":"Juge","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"18","key":"10.1016\/j.rmed.2026.109066_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells12182235","article-title":"Molecular factors in PAD2 (PADI2) and PAD4 (PADI4) are associated with interstitial lung disease susceptibility in rheumatoid arthritis patients","volume":"12","author":"Nava-Quiroz","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.rmed.2026.109066_bib8","article-title":"Rheumatoid arthritis-associated interstitial lung disease: a review","volume":"89","author":"David","year":"2026","journal-title":"Respir. Med. Res."},{"issue":"12","key":"10.1016\/j.rmed.2026.109066_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/acr2.11736","article-title":"Clinical course of interstitial lung disease in patients with rheumatoid arthritis","volume":"6","author":"Matteson","year":"2024","journal-title":"ACR Open Rheumatol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib10","first-page":"90","article-title":"Real-world screening for interstitial lung disease in rheumatoid arthritis: the value of spirometry, DLCO, and clinical risk factors","volume":"64","author":"Dinache","year":"2026","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.rmed.2026.109066_bib11","doi-asserted-by":"crossref","unstructured":"Takeshita M, Suzuki K, Nakazawa M, et al. Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease. J. Autoimmun. 121:102661.","DOI":"10.1016\/j.jaut.2021.102661"},{"issue":"19","key":"10.1016\/j.rmed.2026.109066_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914509","article-title":"Etiology and pathogenesis of rheumatoid arthritis-interstitial lung disease","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/ACI.0000000000000966","article-title":"Association between silicosis and autoimmune disease","volume":"24","author":"Fireman","year":"2024","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.rmed.2026.109066_bib14","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1007\/s10067-025-07627-1","article-title":"Nonlinear association between rheumatoid factor and interstitial lung disease risk in patients with rheumatoid arthritis","volume":"44","author":"Li","year":"2025","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.rmed.2026.109066_bib15","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1007\/s10067-021-05808-2","article-title":"Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis","volume":"40","author":"Xie","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40744-021-00288-x","article-title":"Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese population","volume":"8","author":"Zheng","year":"2021","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.rmed.2026.109066_bib17","doi-asserted-by":"crossref","unstructured":"Triggianese P, Conigliaro P, De Martino E, Monosi B, Chimenti MS. Overview on the link between the complement system and auto-immune articular and pulmonary disease. Open Acc. Rheumatol. 15:65-79.","DOI":"10.2147\/OARRR.S318826"},{"issue":"5","key":"10.1016\/j.rmed.2026.109066_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","article-title":"Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease","volume":"79","author":"Castellanos-Moreira","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.rmed.2026.109066_bib19","doi-asserted-by":"crossref","unstructured":"Koulouri V, Bakasis AD, Marketos N, et al. Scleroderma specific autoantibodies in rheumatoid arthritis and Sj\u00f6gren\u2019s syndrome patients with interstitial lung disease: prevalence and associations. J. Transl. Autoimmun. 6:100183.","DOI":"10.1016\/j.jtauto.2022.100183"},{"key":"10.1016\/j.rmed.2026.109066_bib20","doi-asserted-by":"crossref","unstructured":"Xu X, Zhu L, Li S, Wang G, Ge Y. Clinical features and prognosis of double-positive Anti-MDA5 and Anti-CCP antibodies in dermatomyositis: a retrospective study. J. Inflamm. Res. 18:1929-1939.","DOI":"10.2147\/JIR.S503120"},{"key":"10.1016\/j.rmed.2026.109066_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.937561","article-title":"Treating autoimmune-related interstitial lung disease with B cell depletion","volume":"9","author":"Liossis","year":"2022","journal-title":"Front. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.109066_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103922","article-title":"Updated systematic literature review and meta-analysis to inform the Italian society of rheumatology recommendations on the treatment of rheumatoid arthritis-associated interstitial lung disease","volume":"24","author":"Fassio","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.rmed.2026.109066_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/art.41554","article-title":"Distinct expression of coinhibitory molecules on alveolar T cells in patients with rheumatoid arthritis-associated and idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"73","author":"Nakazawa","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.rmed.2026.109066_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/art.70066","article-title":"Single-cell analysis reveals peripheral helper T cells in rheumatoid arthritis-related interstitial lung disease","author":"Suga","year":"2026","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12931-025-03111-1","article-title":"Neutrophil extracellular traps (NETs) are increased in rheumatoid arthritis-associated interstitial lung disease","volume":"26","author":"Xue","year":"2025","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2026.109066_bib26","doi-asserted-by":"crossref","unstructured":"Venetsanopoulou AI, Ntinopoulou M, Papagianni E, Koletsos N, Voulgari PV, Chrysanthopoulou A. Neutrophil extracellular traps as immunofibrotic mediators in RA-ILD; pilot evaluation of the nintedanib therapy. Front. Immunol. 15:1480594.","DOI":"10.3389\/fimmu.2024.1480594"},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.17219\/acem\/186365","article-title":"Ethoxyquin mediates lung fibrosis and cellular immunity in BLM-CIA mice by inhibiting HSP90","volume":"34","author":"Huang","year":"2025","journal-title":"Adv. Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109066_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/joim.70030","article-title":"Systemic neutrophil activation and N-formyl methionine-formyl peptide receptor-1 signaling define inflammatory endotypes in rheumatoid arthritis-associated lung involvement","volume":"298","author":"Shi","year":"2025","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.rmed.2026.109066_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071581","article-title":"Inhibition of matrix Metalloproteinase-7 attenuates subpleural fibrosis in rheumatoid arthritis-associated interstitial lung disease","volume":"13","author":"Xiong","year":"2025","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.rmed.2026.109066_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.70023","article-title":"Successful treatment of rheumatoid arthritis-associated interstitial lung disease with filgotinib: a case report on janus kinase 1 inhibition","volume":"12","author":"Sunaga","year":"2024","journal-title":"Respirol. Case Rep."},{"issue":"5","key":"10.1016\/j.rmed.2026.109066_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ph14050474","article-title":"Treatment with an Anti-CX3CL1 antibody suppresses M1 macrophage infiltration in interstitial lung disease in SKG mice","volume":"14","author":"Mizutani","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.rmed.2026.109066_bib32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.62438\/tunismed.v102i12.5024","article-title":"RS35705950 polymorphism of MUC5B gene: Association with rheumatoid arthritis and interstitial lung disease in Tunisian population","volume":"102","author":"Saad","year":"2024","journal-title":"Tunis. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/ard-2024-226391","article-title":"Uncovering specific genetic-respiratory disease endotypes for rheumatoid arthritis risk","volume":"84","author":"Kronzer","year":"2025","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.rmed.2026.109066_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/genes14112084","article-title":"Association of a single nucleotide variant in TERT with airway disease in Japanese rheumatoid arthritis patients","volume":"14","author":"Higuchi","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.rmed.2026.109066_bib35","doi-asserted-by":"crossref","unstructured":"Wheeler AM, Baker JF, Poole JA, et al. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease. Semin. Arthritis Rheum. 57:152098.","DOI":"10.1016\/j.semarthrit.2022.152098"},{"issue":"6","key":"10.1016\/j.rmed.2026.109066_bib36","doi-asserted-by":"crossref","first-page":"L1006","DOI":"10.1152\/ajplung.00292.2021","article-title":"IL-23 amplifies the epithelial-mesenchymal transition of mechanically conditioned alveolar epithelial cells in rheumatoid arthritis-associated interstitial lung disease through mTOR\/S6 signaling","volume":"321","author":"Zhang","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.rmed.2026.109066_bib37","doi-asserted-by":"crossref","unstructured":"Li X, Wang J, Zhang X, et al. Naringin nanoparticles alleviate RA-ILD pulmonary fibrosis by targeting 14-3-3\u03b6 to inhibit LYVE1+ macrophages TGF-\u03b21 secretion. Mater. Today Bio. 37:102982.","DOI":"10.1016\/j.mtbio.2026.102982"},{"issue":"3","key":"10.1016\/j.rmed.2026.109066_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5152\/eurjrheum.2021.21102","article-title":"Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease","volume":"9","author":"Bes","year":"2022","journal-title":"Eur. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109066_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00345-2021","article-title":"Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model","volume":"7","author":"Miura","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.rmed.2026.109066_bib40","unstructured":"Chang SH, Paudel ML, McDermott GC, et al. Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: the prospective KORAIL cohort. Semin. Arthritis Rheum. 73:152729."},{"key":"10.1016\/j.rmed.2026.109066_bib41","doi-asserted-by":"crossref","unstructured":"Chen N, Diao CY, Gao J, Zhao DB. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: clinical features, biomarkers, and treatment options. Semin. Arthritis Rheum. 55:152004.","DOI":"10.1016\/j.semarthrit.2022.152004"},{"issue":"7","key":"10.1016\/j.rmed.2026.109066_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15072735","article-title":"Clinical factors associated with hrCT-Confirmed interstitial lung disease in rheumatoid arthritis: a retrospective case-control study","volume":"15","author":"Dinache","year":"2026","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109066_bib43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3899\/jrheum.200863","article-title":"Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease","volume":"48","author":"Kronzer","year":"2021","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.rmed.2026.109066_bib44","doi-asserted-by":"crossref","unstructured":"Ma A, Huang R, Guo J, et al. Association of combined pulmonary fibrosis and emphysema in rheumatoid arthritis with high titer of rheumatoid factor and autoimmunity to the lung. Front. Immunol. 16:1514552.","DOI":"10.3389\/fimmu.2025.1514552"},{"issue":"3","key":"10.1016\/j.rmed.2026.109066_bib45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.31138\/mjr.050325.erl","article-title":"Rheumatoid lung disease","volume":"36","author":"Drosos","year":"2025","journal-title":"Mediterr J. Rheumatol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13075-024-03333-6","article-title":"Rheumatoid arthritis disease activity significantly impacts on the severity of interstitial lung disease","volume":"26","author":"Ito","year":"2024","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.rmed.2026.109066_bib47","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s10067-021-06040-8","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis","volume":"41","author":"Rojas-Serrano","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.rmed.2026.109066_bib48","first-page":"1280","article-title":"Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis","volume":"40","author":"Zheng","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.rmed.2026.109066_bib49","doi-asserted-by":"crossref","unstructured":"Dong R, Sun Y, Xu W, et al. Distribution and clinical significance of anti-carbamylation protein antibodies in rheumatological diseases among the Chinese Han population. Front. Immunol. 14:1197458.","DOI":"10.3389\/fimmu.2023.1197458"},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12865-021-00460-6","article-title":"Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis","volume":"22","author":"Xu","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.rmed.2026.109066_bib51","doi-asserted-by":"crossref","unstructured":"Fang Q, Xie J, Zong J, et al. Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease. Int. Immunopharmacol. 134:112173.","DOI":"10.1016\/j.intimp.2024.112173"},{"issue":"7","key":"10.1016\/j.rmed.2026.109066_bib52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/art.43113","article-title":"Associations of fire smoke and other pollutants with incident rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease","volume":"77","author":"Kronzer","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.rmed.2026.109066_bib53","doi-asserted-by":"crossref","unstructured":"Mikuls TR, Gaurav R, Thiele GM, et al. The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease. Int. Immunopharmacol. 100:108069.","DOI":"10.1016\/j.intimp.2021.108069"},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib54","article-title":"The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"56","author":"Wang","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.rmed.2026.109066_bib55","doi-asserted-by":"crossref","unstructured":"Ba X, Wang H, Huang Y, et al. Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2\/STAT3 and TGF-\u03b2\/Smad2\/3 signalling pathway. J. Ethnopharmacol. 309:116274.","DOI":"10.1016\/j.jep.2023.116274"},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00337-2020","article-title":"Methotrexate and rheumatoid arthritis associated interstitial lung disease","volume":"57","author":"Juge","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2026.109066_bib57","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/rheumatology\/keac651","article-title":"Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease","volume":"62","author":"Kim","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2026.109066_bib58","doi-asserted-by":"crossref","unstructured":"Min HK, Kim SH, Lee SH, Kim HR. Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry. Ther. Adv. Musculoskelet. Dis. 16:1759720X231218098.","DOI":"10.1177\/1759720X231218098"},{"issue":"4","key":"10.1016\/j.rmed.2026.109066_bib59","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/rheumatology\/keaa577","article-title":"Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study","volume":"60","author":"Kelly","year":"2021","journal-title":"Rheumatology"},{"issue":"13","key":"10.1016\/j.rmed.2026.109066_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14131430","article-title":"The burden of interstitial lung involvement in rheumatoid arthritis: could lung ultrasound have a role in its detection? A literature review","volume":"14","author":"Lepri","year":"2024","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.rmed.2026.109066_bib61","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/rheumatology\/kead027","article-title":"Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease","volume":"62","author":"Chang","year":"2023","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rmed.2026.109066_bib62","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1093\/rheumatology\/keac208","article-title":"The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease","volume":"61","author":"Brooks","year":"2022","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.rmed.2026.109066_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13061463","article-title":"Predictive biomarkers and novel treatments for the progressive fibrosing phenotype in interstitial lung disease associated with connective tissue disease","volume":"13","author":"Chung","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41927-024-00403-9","article-title":"Exploring rheumatoid arthritis associated interstitial lung disease a retrospective study from two Saudi tertiary care centers","volume":"8","author":"Boudal","year":"2024","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.rmed.2026.109066_bib65","doi-asserted-by":"crossref","unstructured":"Cela E, Bonini C, Cavalli F, et al. Validation of \u201cClinical Red Flags\u201d for RA-ILD in an Italian cohort. Front. Med. 12:1625742.","DOI":"10.3389\/fmed.2025.1625742"},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib66","article-title":"Rheumatoid arthritis related interstitial lung disease: patterns of high-resolution computed tomography","volume":"12","author":"Gautam","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib67","first-page":"202","article-title":"[Chest High-resolution Computed Tomography Imaging Features of Lung Involvement in Rheumatoid Arthritis]","volume":"42","author":"Song","year":"2020","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"4","key":"10.1016\/j.rmed.2026.109066_bib68","doi-asserted-by":"crossref","first-page":"320","DOI":"10.63032\/PQTT9927","article-title":"Methotrexate-associated pneumonitis: usefulness of lung ultrasound","volume":"4","author":"Cort\u00e9s","year":"2025","journal-title":"ARP Rheumatol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00292-020-00902-9","article-title":"[Interstitial lung disease associated with connective tissue disease]","volume":"42","author":"Fisseler-Eckhoff","year":"2021","journal-title":"Pathologe"},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2214\/AJR.17.18384","article-title":"CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis","volume":"210","author":"Chung","year":"2018","journal-title":"AJR Am. J. Roentgenol."},{"issue":"7","key":"10.1016\/j.rmed.2026.109066_bib71","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s10067-025-07511-y","article-title":"Computed tomography-based quantitative scoring system for rheumatoid arthritis-associated interstitial lung disease: a retrospective diagnostic accuracy study for progressive fibrosis detection","volume":"44","author":"Karacao\u011flu","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.rmed.2026.109066_bib72","doi-asserted-by":"crossref","unstructured":"Venerito V, Manfredi A, Lopalco G, et al. Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: a proof-of-concept study. Front. Med. 9:1069486.","DOI":"10.3389\/fmed.2022.1069486"},{"key":"10.1016\/j.rmed.2026.109066_bib73","doi-asserted-by":"crossref","unstructured":"Dhahri R, Mejri I, Ouslati I, et al. Rheumatoid arthritis associated interstitial lung disease: diagnostic accuracy of lung ultrasound compared to chest high resolution computed tomography. Front. Med. 13:1774934.","DOI":"10.3389\/fmed.2026.1774934"},{"issue":"6","key":"10.1016\/j.rmed.2026.109066_bib74","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.chest.2024.11.038","article-title":"Performance of lung ultrasound as a screening tool for subclinical rheumatoid arthritis-associated interstitial lung disease: a multicenter study","volume":"167","author":"Otaola","year":"2025","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2026.109066_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5152\/TurkThoracJ.2022.21263","article-title":"Screening for subclinical interstitial lung disease in rheumatoid arthritis patients: functional and radiological methods","volume":"23","author":"Abdelwahab","year":"2022","journal-title":"Turk Thorac J."},{"key":"10.1016\/j.rmed.2026.109066_bib76","doi-asserted-by":"crossref","unstructured":"Kim K, Woo A, Park Y, et al. Protective effect of methotrexate on lung function and mortality in rheumatoid arthritis-related interstitial lung disease: a retrospective cohort study. Ther. Adv. Respir. Dis. 16:17534666221135314.","DOI":"10.1177\/17534666221135314"},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2025.107340","article-title":"The utility of lung ultrasound and KL-6 values for the screening of rheumatoid arthritis-associated interstitial lung disease: an exploratory study","volume":"166","author":"Casafont-Sol\u00e9","year":"2026","journal-title":"Med. Clin."},{"key":"10.1016\/j.rmed.2026.109066_bib78","doi-asserted-by":"crossref","unstructured":"Zhang X, Shi M, Guo D, Yu Y, Zhang H, Chen G. Elevated serum Slit3 independently predicts disease activity and interstitial lung disease in rheumatoid arthritis. Clinics. 81:100935.","DOI":"10.1016\/j.clinsp.2026.100935"},{"key":"10.1016\/j.rmed.2026.109066_bib79","doi-asserted-by":"crossref","unstructured":"Yoo H, Hino T, Hwang J, et al. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management. Eur. J. Radiol. Open. 9:100419.","DOI":"10.1016\/j.ejro.2022.100419"},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib80","article-title":"Interstitial lung disease in systemic autoimmune rheumatic diseases: radiologic and histologic correlations","volume":"10","author":"Pye","year":"2026","journal-title":"Rheumatol. Adv. Pract."},{"issue":"6","key":"10.1016\/j.rmed.2026.109066_bib81","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17476348.2024.2374910","article-title":"Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis\/dermatomyositis (PM\/DM-ILD): development of expert consensus-based clinical algorithms","volume":"18","author":"Kondoh","year":"2024","journal-title":"Expert Rev. Respir. Med."},{"issue":"8","key":"10.1016\/j.rmed.2026.109066_bib82","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.42861","article-title":"American college of rheumatology (ACR)\/American college of chest physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"19","key":"10.1016\/j.rmed.2026.109066_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13195871","article-title":"The therapeutic efficacy of abatacept for rheumatoid arthritis-associated interstitial lung disease: insights from a 12-Month trial using semi-quantitative chest high-resolution computed tomography imaging","volume":"13","author":"Shoda","year":"2024","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002359","article-title":"A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases","volume":"8","author":"Kastrati","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.rmed.2026.109066_bib85","doi-asserted-by":"crossref","unstructured":"Parisi S, Ditto MC, Ghellere F, et al. Update on tocilizumab in rheumatoid arthritis: a narrative review. Front. Immunol. 16:1470488.","DOI":"10.3389\/fimmu.2025.1470488"},{"issue":"6","key":"10.1016\/j.rmed.2026.109066_bib86","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00393-023-01434-2","article-title":"[Is JAK inhibition an option in the treatment of interstitial lung disease in rheumatoid arthritis?","volume":"83","author":"Hoffmann","year":"2024","journal-title":"Z. Rheumatol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.70502","article-title":"Rheumatoid arthritis preceded by interstitial lung disease controlled by long-term treatment with the Janus kinase 1-Selective inhibitor, filgotinib: a case report","volume":"14","author":"Sato","year":"2026","journal-title":"Respirol. Case Rep."},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","article-title":"Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"22","key":"10.1016\/j.rmed.2026.109066_bib89","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","article-title":"Nerandomilast in patients with progressive pulmonary fibrosis","volume":"392","author":"Maher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.109066_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2026.03.027","article-title":"Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial","author":"Hoffmann-Vold","year":"2026","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2026.109066_bib91","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2026.109066_bib92","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109066_bib93","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/BOR.0000000000000703","article-title":"Management issues in rheumatoid arthritis-associated interstitial lung disease","volume":"32","author":"England","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"issue":"20","key":"10.1016\/j.rmed.2026.109066_bib94","first-page":"1567","article-title":"[Correlation analysis of Sema4D with rheumatoid arthritis disease activity, bone destruction and rheumatoid arthritis-related interstitial lung disease]","volume":"100","author":"Yang","year":"2020","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"2","key":"10.1016\/j.rmed.2026.109066_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.chpulm.2025.100159","article-title":"Pragmatic comparative effectiveness trials in rheumatoid arthritis-associated interstitial lung disease: a multiperspective qualitative study","volume":"3","author":"Kaczorowski-Worthley","year":"2025","journal-title":"CHEST Pulm."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:41:28Z","timestamp":1793374888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":95,"alternative-id":["S0954611126004348"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109066","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109066"}}